Royce & Associates’s Marex Group Limited Ordinary Shares MRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$67.7M Sell
1,111,339
-141,451
-11% -$7.78M 0.55% 28
2026
Q1
$55.8M Sell
1,252,790
-7,919
-0.6% -$313K 0.55% 30
2025
Q4
$48.4M Sell
1,260,709
-158,223
-11% -$5.38M 0.49% 35
2025
Q3
$47.7M Buy
1,418,932
+459,998
+48% +$16.6M 0.48% 36
2025
Q2
$37.8M Sell
958,934
-496,275
-34% -$20.7M 0.39% 61
2025
Q1
$51.4M Buy
1,455,209
+6,118
+0.4% +$213K 0.56% 26
2024
Q4
$45.2M Buy
1,449,091
+232,491
+19% +$6.51M 0.42% 50
2024
Q3
$28.7M Sell
1,216,600
-103,144
-8% -$2.3M 0.26% 110
2024
Q2
$26.4M Buy
+1,319,744
New +$25.9M 0.25% 115

Other funds holding MRX

Royce & Associates's MRX Position: Q2 2026 in Review

Royce & Associates reduced its Marex Group Limited Ordinary Shares (MRX) stake by 11% in Q2 2026, selling an estimated $7.78M and leaving 1,111,339 shares worth $67.7M. The position accounts for 0.55% of the portfolio, ranked #28.

Royce & Associates first reported a position in MRX in Q2 2024 and has held it in 9 quarters since. 220 funds tracked by Wall St. Rank hold MRX as of Q2 2026.

  • Royce & Associates held 1,111,339 shares of Marex Group Limited Ordinary Shares worth $67.7M as of Q2 2026.
  • Royce & Associates sold 141,451 Marex Group Limited Ordinary Shares shares in Q2 2026, an estimated $7.78M.
  • Marex Group Limited Ordinary Shares made up 0.55% of Royce & Associates's portfolio in Q2 2026, its #28 holding.
  • Royce & Associates first reported a position in Marex Group Limited Ordinary Shares in Q2 2024 and has held it in 9 quarters since.
  • 220 funds tracked by Wall St. Rank held Marex Group Limited Ordinary Shares as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.